MedTrace Logo

Fixed-Free HTN Trial

NCT03578042 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2018-07-05

No results posted yet for this study

Summary

Evaluation of the effect of FIXED triple anti-hypertensive therapy with losartan-amlodipin-HCTZ vs any free triple combination therapy chosen by the treating physician for patients with uncontrolled hypertension

Conditions

Interventions

DRUG

Losartan and amlodipine and hydrochlorothiazide

this is a fixed combination containing the 3 drugs

DRUG

Standard of care

any free triple combination therapy for hypertension given as 2 or 3 pills

Sponsors & Collaborators

  • Hotel Dieu de France Hospital

    lead OTHER

Principal Investigators

  • Rabih R Azar, MD, MPH · Hotel Dieu de France Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-01
Primary Completion
2019-09-30
Completion
2019-12-30

Countries

  • Lebanon

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03578042 on ClinicalTrials.gov